Home / Resource Library / Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity

Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity

Study examined biomarkers associated with bleomycin toxicity in Hodgkin lymphoma.